Literature DB >> 8355507

Expression of differentially phosphorylated Rb and mutant p53 proteins in myeloid leukemia cell lines.

S Sen1, R Takahashi, S Rani, E J Freireich, S A Stass.   

Abstract

We studied the structure and expression of Rb and p53 genes in six myeloid leukemia cell lines (HL-60, KBM3, K562, KBM5, EM2, KBM7) in the light of the published reports that structural abnormalities of these genes are rarely seen in leukemic cells and also a recent finding that Rb gene expression can be regulated by the p53 protein. Except for HL-60 cells which have a truncated p53 gene, none of the other cell lines revealed any gross structural abnormalities in the Rb and p53 genes. KBM3, KBM5 and EM-2 expressed lower levels of Rb mRNA than HL-60, K562 and KBM7. The amount of Rb protein was lowest in KBM3 cells and in this and two other cell lines (KBM5, KBM7) Rb was markedly hypophosphorylated compared to the other three cell lines. HL-60 and K562 did not express p53 m-RNA, while the other four cell lines all expressed high levels of mutant p53 protein. Thus even in the absence of gross structural alterations, subtle abnormalities in the expression pattern of Rb and p53 genes occur in myeloid leukemia cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355507     DOI: 10.1016/0145-2126(93)90068-v

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  6 in total

1.  Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and -independent imatinib resistance.

Authors:  Joya Chandra; Jeannette Tracy; David Loegering; Karen Flatten; Srdan Verstovsek; Miloslav Beran; Mercedes Gorre; Zeev Estrov; Nicholas Donato; Moshe Talpaz; Charles Sawyers; Kapil Bhalla; Judith Karp; Edward Sausville; Scott H Kaufmann
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

2.  Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells.

Authors:  J Schwaller; H P Koeffler; G Niklaus; P Loetscher; S Nagel; M F Fey; A Tobler
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

3.  Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cells.

Authors:  Hairong Song; Mona Fares; Kim R Maguire; Ake Sidén; Zuzana Potácová
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

4.  Aurora A Kinase Inhibitor AKI603 Induces Cellular Senescence in Chronic Myeloid Leukemia Cells Harboring T315I Mutation.

Authors:  Le-Xun Wang; Jun-Dan Wang; Jia-Jie Chen; Bing Long; Ling-Ling Liu; Xi-Xiang Tu; Yu Luo; Yuan Hu; Dong-Jun Lin; Gui Lu; Zi-Jie Long; Quentin Liu
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

5.  4-Nerolidylcatechol: apoptosis by mitochondrial mechanisms with reduction in cyclin D1 at G0/G1 stage of the chronic myelogenous K562 cell line.

Authors:  Polyana Lopes Benfica; Renato Ivan de Ávila; Bruna Dos Santos Rodrigues; Alane Pereira Cortez; Aline Carvalho Batista; Marilisa Pedroso Nogueira Gaeti; Eliana Martins Lima; Kênnia Rocha Rezende; Marize Campos Valadares
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

6.  p53 causes butein‑mediated apoptosis of chronic myeloid leukemia cells.

Authors:  Sang-Mi Woo; Youn Kynug Choi; Ah Jeong Kim; Sung-Gook Cho; Seong-Gyu Ko
Journal:  Mol Med Rep       Date:  2015-12-10       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.